Long term complete response of advanced hepatocellular carcinoma to glypican-3 specific chimeric antigen receptor T-Cells plus sorafenib, a case report.
Sun H, Xing C, Jiang S, Yu K, Dai S, Kong H, Jin Y, Shan Y, Yang W, Wang Z, Xiao J, Wang H, Wang W, Li Z, Shi K.
Sun H, et al. Among authors: wang h, wang w, wang z.
Front Immunol. 2022 Aug 17;13:963031. doi: 10.3389/fimmu.2022.963031. eCollection 2022.
Front Immunol. 2022.
PMID: 36059488
Free PMC article.